Literature DB >> 11248084

Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration.

H C Ha1, K Juluri, Y Zhou, S Leung, M Hermankova, S H Snyder.   

Abstract

Poly(ADP-ribose) polymerase-1 (PARP-1; EC ) is an abundant nuclear enzyme, activated by DNA strand breaks to attach up to 200 ADP-ribose groups to nuclear proteins. As retroviral infection requires integrase-catalyzed DNA strand breaks, we examined infection of pseudotyped HIV type I in fibroblasts from mice with a targeted deletion of PARP-1. Viral infection is almost totally abolished in PARP-1 knockout fibroblasts. This protection from infection reflects prevention of viral integration into the host genome. These findings suggest a potential for PARP inhibitors in therapy of HIV type I infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248084      PMCID: PMC30659          DOI: 10.1073/pnas.051633498

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

Review 1.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

Authors:  D D'Amours; S Desnoyers; I D'Silva; G G Poirier
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

2.  Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

Authors:  R Sanchez-Pescador; M D Power; P J Barr; K S Steimer; M M Stempien; S L Brown-Shimer; W W Gee; A Renard; A Randolph; J A Levy
Journal:  Science       Date:  1985-02-01       Impact factor: 47.728

3.  Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion.

Authors:  H C Ha; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Identification of poly(ADP-ribose) polymerase as a transcriptional coactivator of the human T-cell leukemia virus type 1 Tax protein.

Authors:  M G Anderson; K E Scoggin; C M Simbulan-Rosenthal; J A Steadman
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  DNA-Dependent protein kinase is not required for efficient lentivirus integration.

Authors:  V Baekelandt; A Claeys; P Cherepanov; E De Clercq; B De Strooper; B Nuttin; Z Debyser
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 6.  Poly(ADP-ribose) polymerase-1 in the nervous system.

Authors:  H C Ha; S H Snyder
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

7.  Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase.

Authors:  M Kameoka; K Ota; T Tetsuka; Y Tanaka; A Itaya; T Okamoto; K Yoshihara
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

8.  Inhibitors of poly(adenosine diphosphate-ribose) synthesis: effect on other metabolic processes.

Authors:  K M Milam; J E Cleaver
Journal:  Science       Date:  1984-02-10       Impact factor: 47.728

9.  A comparison of the toxic and SCE-inducing effects of inhibitors of ADP-ribosyl transferase in Chinese hamster ovary cells.

Authors:  S M Morris; R H Heflich
Journal:  Mutat Res       Date:  1984-03       Impact factor: 2.433

Review 10.  Poly(ADP-ribose) and the response of cells to ionizing radiation.

Authors:  N L Oleinick; H H Evans
Journal:  Radiat Res       Date:  1985-01       Impact factor: 2.841

View more
  41 in total

1.  Suppression of retroviral infection by the RAD52 DNA repair protein.

Authors:  Alan Lau; Roland Kanaar; Stephen P Jackson; Mark J O'Connor
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

2.  Ku80 participates in the targeting of retroviral transgenes to the chromatin of CHO cells.

Authors:  Christel Masson; Stéphanie Bury-Moné; Elvire Guiot; Asier Saez-Cirion; Damien Schoëvaërt-Brossault; Corinne Brachet-Ducos; Olivier Delelis; Frédéric Subra; Laurence Jeanson-Leh; Jean-François Mouscadet
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

Review 3.  HIV integrase inhibitors: 20-year landmark and challenges.

Authors:  Mathieu Métifiot; Christophe Marchand; Yves Pommier
Journal:  Adv Pharmacol       Date:  2013

4.  Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus.

Authors:  Ben Readhead; Jean-Vianney Haure-Mirande; Cory C Funk; Matthew A Richards; Paul Shannon; Vahram Haroutunian; Mary Sano; Winnie S Liang; Noam D Beckmann; Nathan D Price; Eric M Reiman; Eric E Schadt; Michelle E Ehrlich; Sam Gandy; Joel T Dudley
Journal:  Neuron       Date:  2018-06-21       Impact factor: 17.173

5.  Poly(ADP-ribose) polymerase 1 is not strictly required for infection of murine cells by retroviruses.

Authors:  Amara C Siva; Frederic Bushman
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.

Authors:  Anne Ahlmann Nielsen; Annette Balle Sørensen; Jörg Schmidt; Finn Skou Pedersen
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Herpes simplex virus 1 infection activates poly(ADP-ribose) polymerase and triggers the degradation of poly(ADP-ribose) glycohydrolase.

Authors:  Sarah L Grady; Jesse Hwang; Livia Vastag; Joshua D Rabinowitz; Thomas Shenk
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

8.  The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription.

Authors:  James G Greger; Richard A Katz; Alexander M Ishov; Gerd G Maul; Anna Marie Skalka
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

9.  Poly(ADP-ribose) polymerase 1 promotes transcriptional repression of integrated retroviruses.

Authors:  Murilo T D Bueno; Daniel Reyes; Luis Valdes; Adarsh Saheba; Eduardo Urias; Crystal Mendoza; Oliver I Fregoso; Manuel Llano
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  Transduction of terminally differentiated neurons by avian sarcoma virus.

Authors:  James G Greger; Richard A Katz; Konstantin Taganov; Glenn F Rall; Anna Marie Skalka
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.